HEADER HYDROLASE 22-APR-17 5NRF
TITLE CRYSTAL STRUCTURE OF HUMAN CHITOTRIOSIDASE-1 (HCHIT) CATALYTIC DOMAIN
TITLE 2 IN COMPLEX WITH COMPOUND 7I
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: CHITOTRIOSIDASE-1;
COMPND 3 CHAIN: A;
COMPND 4 SYNONYM: CHITINASE-1;
COMPND 5 EC: 3.2.1.14;
COMPND 6 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: CHIT1;
SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS;
SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN;
SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606
KEYWDS CHITOTRIOSIDASE-1 (HCHIT) CATALYTIC DOMAIN IN COMPLEX WITH COMPOUND
KEYWDS 2 7I, HYDROLASE
EXPDTA X-RAY DIFFRACTION
AUTHOR M.MAZUR,J.OLCZAK,S.OLEJNICZAK,R.KORALEWSKI,W.CZESTKOWSKI,
AUTHOR 2 A.JEDRZEJCZAK,J.GOLAB,K.DZWONEK,B.DYMEK,P.SKLEPKIEWICZ,A.ZAGOZDZON,
AUTHOR 3 T.NOONAN,K.MAHBOUBI,B.CONWAY,R.SHEELER,P.BECKETT,W.M.HUNGERFORD,
AUTHOR 4 A.PODJARNY,A.MITSCHLER,A.COUSIDO-SIAH,F.FADEL,A.GOLEBIOWSKI
REVDAT 2 13-NOV-24 5NRF 1 REMARK
REVDAT 1 28-MAR-18 5NRF 0
JRNL AUTH M.MAZUR,J.OLCZAK,S.OLEJNICZAK,R.KORALEWSKI,W.CZESTKOWSKI,
JRNL AUTH 2 A.JEDRZEJCZAK,J.GOLAB,K.DZWONEK,B.DYMEK,P.L.SKLEPKIEWICZ,
JRNL AUTH 3 A.ZAGOZDZON,T.NOONAN,K.MAHBOUBI,B.CONWAY,R.SHEELER,
JRNL AUTH 4 P.BECKETT,W.M.HUNGERFORD,A.PODJARNY,A.MITSCHLER,
JRNL AUTH 5 A.COUSIDO-SIAH,F.FADEL,A.GOLEBIOWSKI
JRNL TITL TARGETING ACIDIC MAMMALIAN CHITINASE IS EFFECTIVE IN ANIMAL
JRNL TITL 2 MODEL OF ASTHMA.
JRNL REF J. MED. CHEM. V. 61 695 2018
JRNL REFN ISSN 1520-4804
JRNL PMID 29283260
JRNL DOI 10.1021/ACS.JMEDCHEM.7B01051
REMARK 1
REMARK 1 REFERENCE 1
REMARK 1 AUTH M.MAZUR,J.OLCZAK,S.OLEJNICZAK,R.KORALEWSKI,W.CZESTKOWSKI,
REMARK 1 AUTH 2 A.JEDRZEJCZAK,J.GOLAB,K.DZWONEK,B.DYMEK,P.SKLEPKIEWICZ,
REMARK 1 AUTH 3 A.ZAGOZDZON,T.NOONAN,K.MAHBOUBI,B.CONWAY,R.SHEELER,
REMARK 1 AUTH 4 P.BECKETT,W.M.HUNGERFORD,A.PODJARNY,A.MITSCHLER,
REMARK 1 AUTH 5 A.COUSIDO-SIAH,F.FADEL,A.GOLEBIOWSKI
REMARK 1 TITL TARGETING ACIDIC MAMMALIAN CHITINASE IS EFFECTIVE IN ANIMAL
REMARK 1 TITL 2 MODEL OF ASTHMA
REMARK 1 REF TO BE PUBLISHED
REMARK 1 REFN
REMARK 2
REMARK 2 RESOLUTION. 1.45 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : PHENIX DEV_1255
REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN
REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE,
REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER,
REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY,
REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON,
REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI,
REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT
REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART
REMARK 3
REMARK 3 REFINEMENT TARGET : ML
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.45
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.93
REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360
REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7
REMARK 3 NUMBER OF REFLECTIONS : 67781
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 R VALUE (WORKING + TEST SET) : 0.145
REMARK 3 R VALUE (WORKING SET) : 0.144
REMARK 3 FREE R VALUE : 0.169
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050
REMARK 3 FREE R VALUE TEST SET COUNT : 3422
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS).
REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE
REMARK 3 1 28.9346 - 4.1713 0.97 2905 122 0.1559 0.1481
REMARK 3 2 4.1713 - 3.3124 0.98 2747 162 0.1532 0.1650
REMARK 3 3 3.3124 - 2.8941 0.99 2771 146 0.1646 0.1795
REMARK 3 4 2.8941 - 2.6297 0.99 2745 139 0.1701 0.2109
REMARK 3 5 2.6297 - 2.4413 0.99 2758 136 0.1591 0.1632
REMARK 3 6 2.4413 - 2.2975 0.98 2709 148 0.1500 0.1820
REMARK 3 7 2.2975 - 2.1824 0.99 2689 168 0.1371 0.1466
REMARK 3 8 2.1824 - 2.0875 0.99 2698 140 0.1292 0.1567
REMARK 3 9 2.0875 - 2.0071 0.98 2691 141 0.1213 0.1586
REMARK 3 10 2.0071 - 1.9379 0.99 2682 144 0.1235 0.1544
REMARK 3 11 1.9379 - 1.8773 0.98 2688 143 0.1174 0.1604
REMARK 3 12 1.8773 - 1.8236 0.98 2663 161 0.1216 0.1665
REMARK 3 13 1.8236 - 1.7756 0.98 2672 144 0.1182 0.1760
REMARK 3 14 1.7756 - 1.7323 0.98 2646 160 0.1223 0.1543
REMARK 3 15 1.7323 - 1.6929 0.98 2636 139 0.1247 0.1920
REMARK 3 16 1.6929 - 1.6569 0.97 2657 150 0.1228 0.1643
REMARK 3 17 1.6569 - 1.6238 0.98 2624 141 0.1224 0.1620
REMARK 3 18 1.6238 - 1.5931 0.98 2698 113 0.1236 0.1963
REMARK 3 19 1.5931 - 1.5647 0.97 2580 148 0.1191 0.1568
REMARK 3 20 1.5647 - 1.5382 0.97 2678 139 0.1308 0.1868
REMARK 3 21 1.5382 - 1.5134 0.97 2602 130 0.1364 0.2113
REMARK 3 22 1.5134 - 1.4901 0.97 2664 134 0.1456 0.1825
REMARK 3 23 1.4901 - 1.4682 0.97 2603 140 0.1559 0.1892
REMARK 3 24 1.4682 - 1.4475 0.94 2553 134 0.1715 0.2242
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL
REMARK 3 SOLVENT RADIUS : 1.11
REMARK 3 SHRINKAGE RADIUS : 0.90
REMARK 3 K_SOL : NULL
REMARK 3 B_SOL : NULL
REMARK 3
REMARK 3 ERROR ESTIMATES.
REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.110
REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 14.550
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 TWINNING INFORMATION.
REMARK 3 FRACTION: NULL
REMARK 3 OPERATOR: NULL
REMARK 3
REMARK 3 DEVIATIONS FROM IDEAL VALUES.
REMARK 3 RMSD COUNT
REMARK 3 BOND : 0.005 3298
REMARK 3 ANGLE : 1.169 4483
REMARK 3 CHIRALITY : 0.077 458
REMARK 3 PLANARITY : 0.005 585
REMARK 3 DIHEDRAL : 14.394 1194
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 NCS DETAILS
REMARK 3 NUMBER OF NCS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 5NRF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 24-APR-17.
REMARK 100 THE DEPOSITION ID IS D_1200004595.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 05-DEC-12
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : SLS
REMARK 200 BEAMLINE : X06DA
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.8
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : AIMLESS
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 67782
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.440
REMARK 200 RESOLUTION RANGE LOW (A) : 28.930
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 97.7
REMARK 200 DATA REDUNDANCY : 5.900
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 26.3200
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 45.82
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 25% (W/V) POLYETHYLENE GLYCOL (PEG)
REMARK 280 3350, 200 MM POTASSIUM SODIUM TARTRATE (PST) AT PH 7.2, VAPOR
REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 290K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z
REMARK 290 3555 -X+1/2,Y+1/2,-Z
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 42.82200
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 52.99850
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 42.82200
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 52.99850
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 280 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 15160 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 480
REMARK 480 ZERO OCCUPANCY ATOM
REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO
REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS
REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME;
REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 480 M RES C SSEQI ATOMS
REMARK 480 GLU A 305 N CA C O CB CG CD
REMARK 480 GLU A 305 OE1 OE2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 SER A 226 64.49 -155.31
REMARK 500 THR A 266 34.49 -95.20
REMARK 500 ASP A 328 -125.05 53.80
REMARK 500 ASP A 328 -125.05 52.93
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue 95Q A 401
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 402
DBREF 5NRF A 22 387 UNP Q13231 CHIT1_HUMAN 22 387
SEQADV 5NRF VAL A 388 UNP Q13231 EXPRESSION TAG
SEQADV 5NRF PRO A 389 UNP Q13231 EXPRESSION TAG
SEQADV 5NRF ARG A 390 UNP Q13231 EXPRESSION TAG
SEQADV 5NRF GLY A 391 UNP Q13231 EXPRESSION TAG
SEQADV 5NRF SER A 392 UNP Q13231 EXPRESSION TAG
SEQADV 5NRF HIS A 393 UNP Q13231 EXPRESSION TAG
SEQADV 5NRF HIS A 394 UNP Q13231 EXPRESSION TAG
SEQADV 5NRF HIS A 395 UNP Q13231 EXPRESSION TAG
SEQADV 5NRF HIS A 396 UNP Q13231 EXPRESSION TAG
SEQADV 5NRF HIS A 397 UNP Q13231 EXPRESSION TAG
SEQADV 5NRF HIS A 398 UNP Q13231 EXPRESSION TAG
SEQRES 1 A 377 ALA LYS LEU VAL CYS TYR PHE THR ASN TRP ALA GLN TYR
SEQRES 2 A 377 ARG GLN GLY GLU ALA ARG PHE LEU PRO LYS ASP LEU ASP
SEQRES 3 A 377 PRO SER LEU CYS THR HIS LEU ILE TYR ALA PHE ALA GLY
SEQRES 4 A 377 MET THR ASN HIS GLN LEU SER THR THR GLU TRP ASN ASP
SEQRES 5 A 377 GLU THR LEU TYR GLN GLU PHE ASN GLY LEU LYS LYS MET
SEQRES 6 A 377 ASN PRO LYS LEU LYS THR LEU LEU ALA ILE GLY GLY TRP
SEQRES 7 A 377 ASN PHE GLY THR GLN LYS PHE THR ASP MET VAL ALA THR
SEQRES 8 A 377 ALA ASN ASN ARG GLN THR PHE VAL ASN SER ALA ILE ARG
SEQRES 9 A 377 PHE LEU ARG LYS TYR SER PHE ASP GLY LEU ASP LEU ASP
SEQRES 10 A 377 TRP GLU TYR PRO GLY SER GLN GLY SER PRO ALA VAL ASP
SEQRES 11 A 377 LYS GLU ARG PHE THR THR LEU VAL GLN ASP LEU ALA ASN
SEQRES 12 A 377 ALA PHE GLN GLN GLU ALA GLN THR SER GLY LYS GLU ARG
SEQRES 13 A 377 LEU LEU LEU SER ALA ALA VAL PRO ALA GLY GLN THR TYR
SEQRES 14 A 377 VAL ASP ALA GLY TYR GLU VAL ASP LYS ILE ALA GLN ASN
SEQRES 15 A 377 LEU ASP PHE VAL ASN LEU MET ALA TYR ASP PHE HIS GLY
SEQRES 16 A 377 SER TRP GLU LYS VAL THR GLY HIS ASN SER PRO LEU TYR
SEQRES 17 A 377 LYS ARG GLN GLU GLU SER GLY ALA ALA ALA SER LEU ASN
SEQRES 18 A 377 VAL ASP ALA ALA VAL GLN GLN TRP LEU GLN LYS GLY THR
SEQRES 19 A 377 PRO ALA SER LYS LEU ILE LEU GLY MET PRO THR TYR GLY
SEQRES 20 A 377 ARG SER PHE THR LEU ALA SER SER SER ASP THR ARG VAL
SEQRES 21 A 377 GLY ALA PRO ALA THR GLY SER GLY THR PRO GLY PRO PHE
SEQRES 22 A 377 THR LYS GLU GLY GLY MET LEU ALA TYR TYR GLU VAL CYS
SEQRES 23 A 377 SER TRP LYS GLY ALA THR LYS GLN ARG ILE GLN ASP GLN
SEQRES 24 A 377 LYS VAL PRO TYR ILE PHE ARG ASP ASN GLN TRP VAL GLY
SEQRES 25 A 377 PHE ASP ASP VAL GLU SER PHE LYS THR LYS VAL SER TYR
SEQRES 26 A 377 LEU LYS GLN LYS GLY LEU GLY GLY ALA MET VAL TRP ALA
SEQRES 27 A 377 LEU ASP LEU ASP ASP PHE ALA GLY PHE SER CYS ASN GLN
SEQRES 28 A 377 GLY ARG TYR PRO LEU ILE GLN THR LEU ARG GLN GLU LEU
SEQRES 29 A 377 SER LEU VAL PRO ARG GLY SER HIS HIS HIS HIS HIS HIS
HET 95Q A 401 29
HET GOL A 402 12
HETNAM 95Q 1-(3-AZANYL-1~{H}-1,2,4-TRIAZOL-5-YL)-~{N}-[2-(4-
HETNAM 2 95Q CHLOROPHENYL)ETHYL]-~{N}-(PHENYLMETHYL)PIPERIDIN-4-
HETNAM 3 95Q AMINE
HETNAM GOL GLYCEROL
HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL
FORMUL 2 95Q C22 H27 CL N6
FORMUL 3 GOL C3 H8 O3
FORMUL 4 HOH *200(H2 O)
HELIX 1 AA1 TRP A 31 ARG A 35 5 5
HELIX 2 AA2 GLN A 36 ARG A 40 5 5
HELIX 3 AA3 LEU A 42 LEU A 46 5 5
HELIX 4 AA4 ASN A 72 ASN A 87 1 16
HELIX 5 AA5 THR A 103 ALA A 111 1 9
HELIX 6 AA6 THR A 112 SER A 131 1 20
HELIX 7 AA7 VAL A 150 GLY A 174 1 25
HELIX 8 AA8 GLY A 187 TYR A 195 1 9
HELIX 9 AA9 GLU A 196 LEU A 204 1 9
HELIX 10 AB1 SER A 235 LEU A 241 5 7
HELIX 11 AB2 ASN A 242 LYS A 253 1 12
HELIX 12 AB3 PRO A 256 SER A 258 5 3
HELIX 13 AB4 TYR A 303 CYS A 307 1 5
HELIX 14 AB5 ASP A 336 LYS A 350 1 15
HELIX 15 AB6 ALA A 359 ASP A 363 5 5
HELIX 16 AB7 TYR A 375 LEU A 385 1 11
SHEET 1 AA110 GLN A 65 SER A 67 0
SHEET 2 AA110 HIS A 53 THR A 62 -1 N GLY A 60 O SER A 67
SHEET 3 AA110 LYS A 91 GLY A 97 1 O ALA A 95 N ALA A 59
SHEET 4 AA110 GLY A 134 ASP A 138 1 O ASP A 136 N LEU A 94
SHEET 5 AA110 LEU A 179 PRO A 185 1 O ALA A 183 N LEU A 137
SHEET 6 AA110 PHE A 206 MET A 210 1 O ASN A 208 N ALA A 182
SHEET 7 AA110 LEU A 260 PRO A 265 1 O ILE A 261 N VAL A 207
SHEET 8 AA110 GLY A 354 TRP A 358 1 O MET A 356 N LEU A 262
SHEET 9 AA110 LYS A 23 THR A 29 1 N VAL A 25 O ALA A 355
SHEET 10 AA110 HIS A 53 THR A 62 1 O HIS A 53 N CYS A 26
SHEET 1 AA2 3 ALA A 285 SER A 288 0
SHEET 2 AA2 3 TYR A 267 LEU A 273 -1 N THR A 272 O GLY A 287
SHEET 3 AA2 3 MET A 300 ALA A 302 -1 O LEU A 301 N GLY A 268
SHEET 1 AA3 5 ALA A 285 SER A 288 0
SHEET 2 AA3 5 TYR A 267 LEU A 273 -1 N THR A 272 O GLY A 287
SHEET 3 AA3 5 GLN A 330 GLY A 333 -1 O TRP A 331 N PHE A 271
SHEET 4 AA3 5 VAL A 322 ARG A 327 -1 N ILE A 325 O VAL A 332
SHEET 5 AA3 5 THR A 313 ILE A 317 -1 N GLN A 315 O TYR A 324
SSBOND 1 CYS A 26 CYS A 51 1555 1555 2.04
SSBOND 2 CYS A 307 CYS A 370 1555 1555 2.04
CISPEP 1 ALA A 57 PHE A 58 0 -4.84
CISPEP 2 GLU A 140 TYR A 141 0 -5.29
CISPEP 3 TRP A 358 ALA A 359 0 0.90
SITE 1 AC1 19 TYR A 27 TRP A 99 ASP A 138 GLU A 140
SITE 2 AC1 19 ALA A 183 MET A 210 TYR A 212 ASP A 213
SITE 3 AC1 19 TYR A 267 ARG A 269 THR A 295 GLU A 297
SITE 4 AC1 19 MET A 300 MET A 356 TRP A 358 LEU A 362
SITE 5 AC1 19 ARG A 390 GLY A 391 HOH A 503
SITE 1 AC2 8 TYR A 141 PRO A 185 ALA A 186 GLY A 187
SITE 2 AC2 8 MET A 210 TYR A 212 ASP A 213 HOH A 501
CRYST1 85.644 105.997 42.236 90.00 90.00 90.00 P 21 21 2 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.011676 0.000000 0.000000 0.00000
SCALE2 0.000000 0.009434 0.000000 0.00000
SCALE3 0.000000 0.000000 0.023676 0.00000